POTENTIAL IMPACT & COST-EFFECTIVENESS OF WIDELY ACCESSIBLE TLD IN SUB-SAHARAN AFRICA
Background: Post-exposure prophylaxis (PEP) offers protection from HIV after unanticipated condomless sex, but is not widely available in a timely way in sub-Saharan Africa (SSA). We propose consideration of making tenofovir-lamivudine-dolutegravir (TLD) widely and freely locally available in communities without prescription (e.g. where condoms are made available, along with HIV self-test kits and emergency contraception),…